Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Developing a Successful Crisis Response Team for Young People - WorkshopCYP MH
CYPMH conference 2016 Future in Mind Vision to Implementation
Developing a Successful Crisis Response Team for Young People -
Clare Anderson and team (Tees, Esk and Wear Valleys NHS Foundation Trust)
South Region CCG Mental Health Masterclass - EIP Preparedness ProgrammeSarah Amani
The Early Intervention in Mental Health Network's mission is to improve health and social outcomes for young people with first episode psychosis, including symptom reduction and engagement with education and employment.
This document is the beginning of a programme to help people work together in preparation of the regions task to achieve the above mission.
Early Intervention: Improving Access to Mental Health by 2020 [Presentations]Sarah Amani
Most mental illnesses begin in adolescence or early adulthood – the vital time in life when we establish our independence. Mental illness can derail this process with long-lasting effects. We know that the earlier we can engage a young person in treatment the better their outcomes – but young people are the least likely to seek help from mental health services. This is not helped by the separation of services at age 18.
The good news is that we know that early intervention makes a difference in getting young people well and keeping them well. Early intervention teams have been established for psychosis in England for the last 12 years. Psychosis is a serious mental illness affecting 1-2% of the population, with about 500 new cases every year in the Oxford AHSN area.
Early intervention in psychosis is a specialist, community-based service providing medical, psychological and family-based treatments. It helps get young people back to work or education and keeps an eye out for any early signs of relapse so that they can be prevented. Early intervention teams are highly valued by young people and their families. They also save the health service money by keeping people well and getting them back to work.
The Early intervention in mental health network will make sure that this best practice is in place across the Oxford AHSN region with the highest standard of care provided everywhere. We also aim to spread this early intervention model across other conditions (such as eating disorders, personality disorder, autistic spectrum conditions) to help more young people.
World class research is being undertaken in Oxford AHSN and across England into early psychosis – both into the causes and to trial new treatments. We aim to make this research available to every patient being seen by our early intervention teams. We will also look to develop new innovations and technologies that could improve the experience of young people receiving mental healthcare.
Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Developing a Successful Crisis Response Team for Young People - WorkshopCYP MH
CYPMH conference 2016 Future in Mind Vision to Implementation
Developing a Successful Crisis Response Team for Young People -
Clare Anderson and team (Tees, Esk and Wear Valleys NHS Foundation Trust)
South Region CCG Mental Health Masterclass - EIP Preparedness ProgrammeSarah Amani
The Early Intervention in Mental Health Network's mission is to improve health and social outcomes for young people with first episode psychosis, including symptom reduction and engagement with education and employment.
This document is the beginning of a programme to help people work together in preparation of the regions task to achieve the above mission.
Early Intervention: Improving Access to Mental Health by 2020 [Presentations]Sarah Amani
Most mental illnesses begin in adolescence or early adulthood – the vital time in life when we establish our independence. Mental illness can derail this process with long-lasting effects. We know that the earlier we can engage a young person in treatment the better their outcomes – but young people are the least likely to seek help from mental health services. This is not helped by the separation of services at age 18.
The good news is that we know that early intervention makes a difference in getting young people well and keeping them well. Early intervention teams have been established for psychosis in England for the last 12 years. Psychosis is a serious mental illness affecting 1-2% of the population, with about 500 new cases every year in the Oxford AHSN area.
Early intervention in psychosis is a specialist, community-based service providing medical, psychological and family-based treatments. It helps get young people back to work or education and keeps an eye out for any early signs of relapse so that they can be prevented. Early intervention teams are highly valued by young people and their families. They also save the health service money by keeping people well and getting them back to work.
The Early intervention in mental health network will make sure that this best practice is in place across the Oxford AHSN region with the highest standard of care provided everywhere. We also aim to spread this early intervention model across other conditions (such as eating disorders, personality disorder, autistic spectrum conditions) to help more young people.
World class research is being undertaken in Oxford AHSN and across England into early psychosis – both into the causes and to trial new treatments. We aim to make this research available to every patient being seen by our early intervention teams. We will also look to develop new innovations and technologies that could improve the experience of young people receiving mental healthcare.
Mariana Curado Malta, a researcher working in the POSTDATA project of LINHD was invited to talk in the Universidad Carlos III of Madrid on the “Máster Universitario en Bibliotecas y Servicios de Información Digital “ in the topic “Vocabularios y Esquemas semánticos para la Web”. She presented the method for the development of metadata application profiles (Me4MAP) to the students and gave some examples of application of this method, one of these examples was POSTDATA and how the project team is elicitating the functional requirements and defining the domain model.
İnovatif Kimya Dergisi Sayı-7 Anlatılan Konu Başlıkları
İlaç Sektörü ve Kimya
İş Dünyasında Kadın
Geleceğin Malzemesi Akıllı Polimerler
Kimyasal Silahlar
Güneş Termal Enerjisi
SmartDraw Kullanımı ve Yapabileceklerimiz
Ayın Röportajı : Croda Kimya Tic. Ltd. Sti. Ülke Müdürü Mine ENÜSTÜN ile Ayın Röportajı.
Ayrıca Her Ay 3 Web Sitesi ve Kimya Bulmacası ile Kimya Sektöründen Haberler
İyi okumalar dileriz.
iHV regional conference: Josephine Johnson - Health Visitors as leaders in th...Julie Cooper
Presentation by Josephine Johnson at the Institute of Health Visiting Regional Professional Conferences 2015.
Josephine Johnson is Project Lead at NHS England.
Anticipatory Care Planning: Time To Make It Happen - Early Intervention Using The Life curve Dr Sarah Mitchell (Programme Manager - AHP National Delivery Plan)
This event, held in Sheffield Town Hall in 28 May 2015, looked at what health and care could look like in 2020 in Sheffield and considered some of the challenges the system faces.
As health care and financing systems become more sophisticated, health care systems are increasingly using a process known as "risk tiering" to group patients with similar degrees of need for health care and care coordination services. Families and care providers of children with chronic and complex conditions should understand the risk tiering process, as it may affect access to services these children need.
iHV regional conference: Josephine Johnson - Health Visitors as leaders in th...Julie Cooper
Presentation by Josephine Johnson at the Institute of Health Visiting Regional Professional Conferences 2015 - on behalf of Sabrina Fuller, Head of Health Improvement NHS England.
Josephine Johnson is Project Lead, NHS England.
Personal Health Budgets and Continuing HealthcareMS Trust
This presentation by Gill Ruecroft, Commissioning Manager, provides an overview of Personal Health Budgets (PHBs) and demonstrates the effectiveness of PHBs through case studies.
It was presented at the MS Trust Annual Conference in November 2014.
Integrated personal commissioning, innovate stage, 1pm, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
iHV regional conf: Sabrina Fuller - Health Visitors as leaders in the transit...Julie Cooper
Presentation by Sabrina Fuller at the Institute of Health Visiting Regional Professional Conferences 2015.
Sabrina Fuller is Head of Health Improvement, NHS England.
Your opportunity to feedback on stakeholder thinking to date.
Identify opportunities and any challenges in the proposed new ways of working.
To be confident we can bring about the proposed changes by ensuring we have expert views from all those who have a role to play in supporting the implementation.
NICE have now published three guidelines which are relevant to the care and support of older people:
Home care: delivering personal care and practical support to older people living in their own homes
Transition between inpatient hospital settings and community or care home settings for adults with social care needs
Older people with social care needs and multiple long-term conditions
Alongside hosting three workshops, the NICE Collaborating Centre for Social Care is hosting a FREE webinar to introduce these guidelines together and enable frontline practitioners and managers to consider how they can support practice improvement.
Guidance for commissioners of child and adolescent mental health servicesJCP MH
This guide describes what ‘good looks like’ for a modern child and adolescent mental health service (CAMHS). It should be of value to Clinical Commissioning Groups (CCGs) and NHS England.
By the end of this guide, readers should be more familiar with the concept of CAMHS and better equipped to understand:
what a good quality, modern, service looks like
why a good CAMHS delivers the mental health strategy and the Quality Innovation Productivity and Prevention initiative – not only in itself but also by enabling changes in other parts of the system
the benefits of CAMHS to children, young people, their families and carers, and
why CAMHS are important for commissioners.
iHV regional conf: Theresa Bishop - Strengthening Health Visiting into the fu...Julie Cooper
Presentation by Theresa Bishop at the Institute of Health Visiting Regional Professional Conferences 2015.
Theresa Bishop is Professional Lead for Health Visiting in Warwickshire.
Similar to Mental Health Summit 7 June 2016 Presentation 08. Jonathan Prosser (20)
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary,
Review of patients on high dose opioids at Living Well PCN, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfHealth Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving care in County Durham under the STOMP agenda - A 5 year review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Impact of an EMIS search to prioritise care home residents for a pharmacist led medication review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Identifying Orthostatic Hypotension caused by Medication, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
3. CYP Mental Health: Policy Context
• Children and Young People’s Health Outcomes Strategy
• Mental Health Strategy & Implementation Framework
• CYP IAPT
• PbR Development
• Health and Social Care Bill
• SEND Changes –single plan
• Education Act 2011
• OFSTED 2012 framework for school inspection
• CMO Report
• NHS Mandate
• Closing the Gap
• Tier 4 Review
• Crisis Care Concordat
4. SEND
From September 2014 CCGs must:
• commission services jointly for children and young people (up to age 25)
with SEND, including those with Education Health and Care (EHC) plans
• work with the local authority to contribute to the Local Offer of services
available
• have mechanisms in place to ensure practitioners and clinicians will
support the integrated EHC needs assessment process, and
• agree Personal Budgets where they are provided for those with EHC plans
The reforms are focused on enabling children and young people to achieve
the best they can, with an emphasis on outcomes rather than processes.
CCGs and local authorities have considerable freedom in how they work
together to deliver integrated support that improves children and young
peoples’ outcomes.
5. CYP Mental Health: Political Context
• Total NHS Budget of £104,000,000,000
• 10% total NHS budget spent on mental health
• £11,260,000,000 spent on mental health
• £770,000,000 spent on CAMHS
• Which is 7% of MH budget
• And 0.7% of NHS budget
• Does not include figures on psychological
wellbeing spend in social care and education
2009/10 .
10. 5YFV – what does it say?
• 5YFV accepts we will have less money
to spend against increasing need
• 5YFV doesn’t mention children much
except obese ones but…
• 5YFV does talk a lot about prevention
• 5YFV certainly mentions new ways of
working, particularly integrated
(MCP) health and social care
provision
11. What are the problems?
• Tiny resources cf need and potential benefit
• Past silo mentality of CAMHS
• Historically narrow-ish focus
• Historical scheduled care, clinic based focus
• Offer from partners in social care, education
has been changing – 3rd sector stepping in
• Not clear who our lived experience users are
• Massive ‘hidden’ need
12. What are the answers?
• Wider psychological & systems wellbeing focus
• Redistribute, amalgamate and co-opt resources
for better overall benefit
• Re-think extended hours and 24/7 offer
• Integration of community children’s health
services as well as partners in social care,
education and third sector
• Courage to prevent on tight budgets
• New ways of working
13. What are the answers?
• Get money out of T4 private sector IP care
• Co-design and co-deliver services with our
populations – say what?
– Outcomes oriented planning at the outset
– Rationing (time or cash budget)
– Pathway navigation
– Increased range of choices
– Timing of delivery
14. Wishlist
• A step change in user engagement
• Parity of esteem (within children’s and mental health)
• Commissioning for outcomes or joined up care
• Patient held budgets (time or money)
• Single integrated patient held and co-produced health
and social care record, incorporating the twin functions
of recording the past, and planning for the future
• Tech that works and reliable data
• T4 bed money
• Different CPD paradigm (more on the job learning,
observation and apprenticeship)
• Adaptable and responsive workforce (NWW)
15. Workforce?
I’m possibly the wrong person to speak to
this but:
• Some trained workforce is essential!!
• Multidisciplinary workforce is essential
• Mainly there is a need for training to be
about future models of care and
assistance rather than models – wither the
‘evidence base’?
16. The case for CAMHS services
for 0-25 year olds?
• Developmental perspective remains
particularly pertinent in the YA group
• ‘Personality’ is still forming
• Long term outcome focus v relevant
for early presentations of severe and
enduring mental illness